Millennium Management
OTLK icon

Millennium Management’s Outlook Therapeutics OTLK Stock Holding History

Millennium Management’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-164,498
Closed -$260K – 6193
2025
Q4 		$260K Sell
164,498
-30,085
-15% -$48.1K ﹤0.01% 5340
2025
Q3 		$206K Sell
194,583
-143,988
-43% -$249K ﹤0.01% 5533
2025
Q2 		$542K Buy
+338,571
New +$540K ﹤0.01% 4852
2024
Q2 		– Sell
-27,744
Closed -$331K – 6356
2024
Q1 		$331K Buy
27,744
+13,965
+101% +$113K ﹤0.01% 5074
2023
Q4 		$109K Buy
+13,779
New +$116K ﹤0.01% 5328
2023
Q3 		– Sell
-7,187
Closed -$250K – 6434
2023
Q2 		$250K Sell
7,187
-18,587
-72% -$507K ﹤0.01% 5007
2023
Q1 		$562K Buy
25,774
+17,064
+196% +$382K ﹤0.01% 4528
2022
Q4 		$188K Buy
8,710
+2,068
+31% +$45K ﹤0.01% 5356
2022
Q3 		$162K Sell
6,642
-7,883
-54% -$183K ﹤0.01% 5770
2022
Q2 		$296K Sell
14,525
-3,347
-19% -$96.2K ﹤0.01% 5385
2022
Q1 		$636K Sell
17,872
-7,331
-29% -$229K ﹤0.01% 4924
2021
Q4 		$686K Sell
25,203
-22,810
-48% -$814K ﹤0.01% 4764
2021
Q3 		$2.08M Buy
+48,013
New +$2.32M ﹤0.01% 3853
2021
Q2 		– Sell
-10,001
Closed -$450K – 6941
2021
Q1 		$450K Buy
10,001
+971
+11% +$37.2K ﹤0.01% 4906
2020
Q4 		$235K Buy
+9,030
New +$189K ﹤0.01% 4717
2017
Q3 		– Sell
-196
Closed -$31K – 3767
2017
Q2 		$31K Sell
196
-102
-34% -$28.8K ﹤0.01% 3377
2017
Q1 		$128K Sell
298
-70
-19% -$34.8K ﹤0.01% 3298
2016
Q4 		$177K Sell
368
-160
-30% -$89.6K ﹤0.01% 3110
2016
Q3 		$359K Sell
528
-23
-4% -$14.6K ﹤0.01% 2749
2016
Q2 		$300K Buy
+551
New +$329K ﹤0.01% 2725

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Millennium Management's OTLK Position: Q1 2026 in Review

Millennium Management sold out of Outlook Therapeutics (OTLK) in Q1 2026, closing a stake of 164,498 shares — an estimated $260K sold.

Millennium Management first reported a position in OTLK in Q2 2016 and held it in 20 quarters. The position peaked at $2.08M in Q3 2021. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Millennium Management reported no remaining Outlook Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 164,498 Outlook Therapeutics shares in Q1 2026, an estimated $260K.
  • Millennium Management first reported a position in Outlook Therapeutics in Q2 2016 and held it in 20 quarters.
  • Millennium Management's Outlook Therapeutics position peaked at $2.08M in Q3 2021.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.